SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $118K invested in Sonnet BioTherapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$64.1K
2
+$20K
3
+$1.16K
4
Citigroup
Citigroup
New York
+$71
5
Bank of America
Bank of America
North Carolina
+$11

Top Sellers

1
-$76K
2
-$51.2K
3
-$154
4
BlackRock
BlackRock
New York
-$134
5
Osaic Holdings
Osaic Holdings
Arizona
-$78
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$64.1K
2
$27.4K
3
$20K
4
$5.07K
5
$967
6
$71
7
$41
8
$11
9
$11
10
$6
11
–
12
–
13
–
14
–